An Austrian biotech firm that moved into Cambridge in 2008 has raised £7.2m (EUR 8m)

“f-star, which has developed novel antibody engineering technology, moved to the Babraham Research campus in March 2008 in order to build closer links with the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge – an acknowledged world leader in antibody science.” More…